MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202618083577 A) filed by Halia Therapeutics, Inc. on July 07, 2026, for Inhibitors Of Nek7 Kinase.
Inventors include Bearss, David James; Kauwe Iii, John Sai Keong; and Mollard, Alexis Henri Abel.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: Compounds having activity as inhibitors of NEK7 are provided. The compounds have Structure (I): (I) or a pharmaceutically acceptable salt, stereoisomer or prodrug thereof, wherein, A, X, Y, R1, R2, R3, R4and R55 are as defined herein. Methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds and methods to modulate the activity of the NLRP3 inflammasome are also provided.
Disclaimer: Curated by HT Syndication.
